This content is machine translated Systemic mastocytosis Diagnostics and drug therapy approaches – an update A KIT mutation analysis from the bone marrow is recommended in the case of highly elevated tryptase levels. In particular, adults often have a point mutation in codon 816 of…
View Post 5 min This content is machine translated EHA Congress in Madrid Earlier response does not translate into higher overall survival in CML Overall survival of patients with chronic myeloid leukemia cannot be altered by optimizations of imatinib therapy. This is despite the fact that earlier evaluations were able to demonstrate an influence…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
View Post 4 min This content is machine translated World Congress of Dermatology Scalp and hair in focus The 23rd World Congress of Dermatology was held in Vancouver in June. In addition to the large, prominently placed studies, various smaller studies were also convincing with their interesting approaches…
View Post 4 min This content is machine translated Hemato-Oncology All hopes lie in targeted therapy What do so-called targeted therapies actually aim at? And what progress has been made in the various hematologic oncologic neoplasms in this regard? At the 21st Symposium Medicine in the…
View Post 6 min This content is machine translated Tyrosine kinase inhibitors and the skin From common to rare side effects Epidermal-growth-factor receptors are found in the skin and sebaceous glands, tyrosine kinase (TK) in keratinizing skin, mucous membranes and hair, and are thus also targets of EGFR- and TK-inhibiting oncologics…
